Global Chemotherapy-Induced Nausea and Vomiting Drugs Market - By Manufacturers, Type and Application, Growth, Trends and Forecast 2015 - 2025

 Published: Nov-2018 |  Format: PDF | 99Strategy |  Number of pages: 77

Snapshot
The global Chemotherapy-Induced Nausea and Vomiting Drugs market will reach xxx Million USD in 2018 and with a CAGR if xx% between 2019-2025. 
Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
        Existing Drugs
        Akynzeo (Netupitant-Palonosetron FDC)
        Aloxi (Palonosetron)
        Emend (Aprepitant)
        Kytril Generic (Granisetron)
        Zofran Generic (Ondansetron)
        Pipeline Drugs
        SUSTOL (Granisetron Injection extended release)
        Rolapitant
Demand Coverage (Market Size & Forecast,  Consumer Distribution):
        Serotonin Receptor Antagonists
        NK1 Receptor Antagonists
Company Coverage (Sales data, Main Products & Services etc.):
        Merck & Co., Inc.
        GlaxoSmithKline plc
        Tesaro, Inc.
        Helsinn Group
        F. Hoffmann-La Roche Ltd.
        Heron Therapeutics, Inc.
        Dr. Reddy's Laboratories Ltd.
        Acacia Pharma
        Sun Pharmaceutical Industry Ltd.
        Otsuka Holdings Co., Ltd.
Major Region Market
        North America
        Europe
        Asia-Pacific
        South America
        Middle East & Africa
Table of Content
1 Industry Overview
    1.1 Chemotherapy-Induced Nausea and Vomiting Drugs Industry
        1.1.1 Overview
        1.1.2 Products of Major Companies
    1.2 Market Segment
        1.2.1 Industry Chain
        1.2.2 Consumer Distribution
    1.3 Price & Cost Overview
2 Chemotherapy-Induced Nausea and Vomiting Drugs Market by Type
    2.1 By Type
       2.1.1 Existing Drugs
       2.1.2 Akynzeo (Netupitant-Palonosetron FDC)
       2.1.3 Aloxi (Palonosetron)
       2.1.4 Emend (Aprepitant)
       2.1.5 Kytril Generic (Granisetron)
       2.1.6 Zofran Generic (Ondansetron)
       2.1.7 Pipeline Drugs
       2.1.8 SUSTOL (Granisetron Injection extended release)
       2.1.9 Rolapitant
    2.2 Market Size by Type
    2.3 Market Forecast by Type
3 Global Market Demand
    3.1 Segment Overview
        3.1.1 Serotonin Receptor Antagonists
        3.1.2 NK1 Receptor Antagonists
    3.2 Market Size by Demand
    3.3 Market Forecast by Demand
4 Major Region Market
    4.1 Global Market Overview
        4.1.1 Market Size & Growth
        4.1.2 Market Forecast
    4.2 Major Region
        4.2.1 Market Size & Growth
        4.2.2 Market Forecast
5 Major Companies List
    5.1 Merck & Co., Inc. (Company Profile, Sales Data etc.)
    5.2 GlaxoSmithKline plc (Company Profile, Sales Data etc.)
    5.3 Tesaro, Inc. (Company Profile, Sales Data etc.)
    5.4 Helsinn Group (Company Profile, Sales Data etc.)
    5.5 F. Hoffmann-La Roche Ltd. (Company Profile, Sales Data etc.)
    5.6 Heron Therapeutics, Inc. (Company Profile, Sales Data etc.)
    5.7 Dr. Reddy's Laboratories Ltd. (Company Profile, Sales Data etc.)
    5.8 Acacia Pharma (Company Profile, Sales Data etc.)
    5.9 Sun Pharmaceutical Industry Ltd. (Company Profile, Sales Data etc.)
    5.10 Otsuka Holdings Co., Ltd. (Company Profile, Sales Data etc.)
6 Conclusion
Please submit the form will contact you within 24 hours. :
Indicates required fields
Please submit the form will contact you within 24 hours. :
Indicates required fields